Amphastar Pharmaceuticals, Inc. (AMPH)
NASDAQ: AMPH · Real-Time Price · USD
28.31
-0.12 (-0.42%)
Mar 31, 2025, 10:13 AM EDT - Market open
Amphastar Pharmaceuticals Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Operating Revenue | 712.81 | 593.24 | 498.99 | 437.77 | 349.85 | Upgrade
|
| Other Revenue | 19.15 | 51.16 | - | - | - | Upgrade
|
| Revenue | 731.97 | 644.4 | 498.99 | 437.77 | 349.85 | Upgrade
|
| Revenue Growth (YoY) | 13.59% | 29.14% | 13.98% | 25.13% | 8.53% | Upgrade
|
| Cost of Revenue | 358.11 | 290.57 | 250.13 | 238.03 | 206.51 | Upgrade
|
| Gross Profit | 373.86 | 353.82 | 248.86 | 199.74 | 143.34 | Upgrade
|
| Selling, General & Admin | 94.52 | 80.39 | 66.59 | 67.12 | 62.86 | Upgrade
|
| Research & Development | 73.91 | 73.74 | 74.77 | 60.93 | 67.23 | Upgrade
|
| Operating Expenses | 168.44 | 154.13 | 141.36 | 128.05 | 130.09 | Upgrade
|
| Operating Income | 205.42 | 199.69 | 107.5 | 71.69 | 13.25 | Upgrade
|
| Interest Expense | -35.34 | -33.06 | -1.85 | -0.89 | -0.37 | Upgrade
|
| Interest & Investment Income | 10.61 | 5.46 | 1.32 | 0.6 | 0.64 | Upgrade
|
| Earnings From Equity Investments | -0.57 | -1.98 | -1.18 | -0.21 | - | Upgrade
|
| Other Non Operating Income (Expenses) | 9.08 | 1.97 | 9.07 | 13.54 | 6.22 | Upgrade
|
| EBT Excluding Unusual Items | 189.19 | 172.08 | 114.86 | 84.73 | 19.74 | Upgrade
|
| Asset Writedown | - | -2.7 | - | - | - | Upgrade
|
| Legal Settlements | - | - | - | 1 | -12.8 | Upgrade
|
| Other Unusual Items | - | - | - | -1.8 | -2.3 | Upgrade
|
| Pretax Income | 189.19 | 169.38 | 114.86 | 83.93 | 4.64 | Upgrade
|
| Income Tax Expense | 29.67 | 31.83 | 23.48 | 20.63 | 3.54 | Upgrade
|
| Earnings From Continuing Operations | 159.52 | 137.55 | 91.39 | 63.3 | 1.1 | Upgrade
|
| Minority Interest in Earnings | - | - | - | -1.19 | 0.31 | Upgrade
|
| Net Income | 159.52 | 137.55 | 91.39 | 62.12 | 1.4 | Upgrade
|
| Net Income to Common | 159.52 | 137.55 | 91.39 | 62.12 | 1.4 | Upgrade
|
| Net Income Growth | 15.98% | 50.51% | 47.12% | 4327.37% | -97.13% | Upgrade
|
| Shares Outstanding (Basic) | 48 | 48 | 49 | 48 | 47 | Upgrade
|
| Shares Outstanding (Diluted) | 52 | 53 | 52 | 50 | 49 | Upgrade
|
| Shares Change (YoY) | -1.78% | 1.09% | 5.31% | 1.34% | -1.57% | Upgrade
|
| EPS (Basic) | 3.29 | 2.85 | 1.88 | 1.30 | 0.03 | Upgrade
|
| EPS (Diluted) | 3.06 | 2.60 | 1.74 | 1.25 | 0.03 | Upgrade
|
| EPS Growth | 17.69% | 49.43% | 39.20% | 4090.97% | -96.96% | Upgrade
|
| Free Cash Flow | 172.35 | 145.34 | 65.15 | 70.54 | 23.41 | Upgrade
|
| Free Cash Flow Per Share | 3.31 | 2.74 | 1.24 | 1.42 | 0.48 | Upgrade
|
| Gross Margin | 51.08% | 54.91% | 49.87% | 45.63% | 40.97% | Upgrade
|
| Operating Margin | 28.06% | 30.99% | 21.54% | 16.38% | 3.79% | Upgrade
|
| Profit Margin | 21.79% | 21.34% | 18.31% | 14.19% | 0.40% | Upgrade
|
| Free Cash Flow Margin | 23.54% | 22.55% | 13.06% | 16.11% | 6.69% | Upgrade
|
| EBITDA | 258.39 | 237.72 | 132.27 | 94.95 | 34.78 | Upgrade
|
| EBITDA Margin | 35.30% | 36.89% | 26.51% | 21.69% | 9.94% | Upgrade
|
| D&A For EBITDA | 52.97 | 38.04 | 24.77 | 23.27 | 21.53 | Upgrade
|
| EBIT | 205.42 | 199.69 | 107.5 | 71.69 | 13.25 | Upgrade
|
| EBIT Margin | 28.06% | 30.99% | 21.54% | 16.38% | 3.79% | Upgrade
|
| Effective Tax Rate | 15.68% | 18.79% | 20.44% | 24.58% | 76.34% | Upgrade
|
| Revenue as Reported | 731.97 | 644.4 | 498.99 | 437.77 | - | Upgrade
|
| Advertising Expenses | 10.5 | 10.4 | 8.7 | 8.1 | 5.8 | Upgrade
|
Updated Mar 3, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.